Forte E, Zhang Z, Thorp EB, Hummel M. CytomegalovirUs Latency And Reactivation: An Intricate Interplay With The Host Immune Response. Front Cell Infect Microbiol. 2020;10:130.
McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Virus Res. 2006;117:90–104.
Reddehase MJ, Lemmermann NAW. Mouse model of cytomegalovirus disease and immunotherapy in the immunocompromised host: predictions for medical translation that survived the “Test of Time”. Viruses. 2018;10:693.
Roddie C, Peggs KS. Immunotherapy for transplantation-associated viral infections. J Clin Invest. 2017;127:2513–22.
Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest. 2011;121:1673–80.
Reddehase MJ. Mutual Interference between Cytomegalovirus and reconstitution of protective immunity after hematopoietic cell transplantation. Front Immunol. 2016;7:294.
Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19:759–73.
Holtappels R, Böhm V, Podlech J, Reddehase MJ. CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model. Med Microbiol Immunol. 2008;197:125–34.
Holtappels R, Becker S, Hamdan S, Freitag K, Podlech J, Lemmermann NA, et al. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial posttransfer expansion of central memory cells but not effector-memory cells. PLoS Pathog. 2023;19:e1011643.
Krmpotić A, Podlech J, Reddehase MJ, Britt WJ, Jonjić S. Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ résumé. Med Microbiol Immunol. 2019;208:415–29.
You Y, Myers RC, Freeberg L, Foote J, Kearney JF, Justement LB, et al. Marginal zone B cells regulate antigen capture by marginal zone macrophages. J Immunol. 2011;186:2172–81.
Kraal G, Mebius R. New insights into the cell biology of the marginal zone of the spleen. Int Rev Cytol. 2006;250:175–215.
Palm AE, Kleinau S. Marginal zone B cells: From housekeeping function to autoimmunity?. J Autoimmun. 2021;119:102627.
Backer RA, Diener N, Clausen BE. Langerin(+)CD8(+) dendritic cells in the splenic marginal zone: not so marginal after all. Front Immunol. 2019;10:741.
Eisenbarth SC. Dendritic cell subsets in T-cell programming: location dictates function. Nat Rev Immunol. 2019;19:89–103.
den Haan JM, Mebius RE, Kraal G. Stromal cells of the mouse spleen. Front Immunol. 2012;3:201.
Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, Grusdat M, et al. Deficiency of the B-cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. J Virol. 2015;89:4748–59.
Frederico B, Chao B, Lawler C, May JS, Stevenson PG. Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol. 2015;96:2314–27.
Liu Y, Xia Y, Qiu CH. Functions of CD169 positive macrophages in human diseases (Review). Biomed Rep. 2021;14:26.
Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol. 2009;90:33–43.
van Dinther D, Veninga H, Iborra S, Borg EGF, Hoogterp L, Olesek K, et al. Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8(+) T-Cell Cross-Priming. Cell Rep. 2018;22:1484–95.
Friedrich SK, Lang PA, Friebus-Kardash J, Duhan V, Bezgovsek J, Lang KS. Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease. Clin Exp Immunol. 2019;195:64–73.
Honke N, Shaabani N, Merches K, Gassa A, Kraft A, Ehrhardt K, et al. Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses. Eur J Immunol. 2016;46:372–80.
Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014;14:571–8.
Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563–604.
Schraml BU, Reis e Sousa C. Defining dendritic cells. Curr Opin Immunol. 2015;32:13–20.
Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity. 2014;40:642–56.
Durai V, Murphy KM. Functions of murine dendritic cells. Immunity. 2016;45:719–36.
Macri C, Pang ES, Patton T, O’Keeffe M. Dendritic cell subsets. Semin Cell Dev Biol. 2018;84:11–21.
Qiu CH, Miyake Y, Kaise H, Kitamura H, Ohara O, Tanaka M. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol. 2009;182:4127–36.
Prendergast KA, Daniels NJ, Petersen TR, Hermans IF, Kirman JR. Langerin(+) CD8α(+) Dendritic Cells Drive Early CD8(+) T-Cell Activation and IL-12 Production During Systemic Bacterial Infection. Front Immunol. 2018;9:953.
Petersen TR, Sika-Paotonu D, Knight DA, Simkins HM, Hermans IF. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines. PLoS One. 2011;6:e17657.
Munks MW, Gold MC, Zajac AL, Doom CM, Morello CS, Spector DH, et al. Genome-wide analysis reveals a highly diverse CD8 T-cell response to murine cytomegalovirus. J Immunol. 2006;176:3760–6.
Waisman A, Croxford AL, Demircik F. New tools to study the role of B cells in cytomegalovirus infections. Med Microbiol Immunol. 2008;197:145–9.
Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature. 2005;438:364–8.
Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT, et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods. 2005;2:419–26.
Demircik F, Buch T, Waisman A. Efficient B-cell depletion via diphtheria toxin in CD19-Cre/iDTR mice. PLoS One. 2013;8:e60643.
Lemmermann NA, Gergely K, Böhm V, Deegen P, Däubner T, Reddehase MJ. Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes. J Virol. 2010;84:1221–36.
Hong S, Zhang Z, Liu H, Tian M, Zhu X, Zhang Z, et al. B cells are the dominant antigen-presenting cells that activate Naïve CD4(+) T cells upon immunization with a virus-derived nanoparticle antigen. Immunity. 2018;49:695–708.e4.
Rastogi I, Jeon D, Moseman JE, Muralidhar A, Potluri HK, McNeel DG. Role of B cells as antigen presenting cells. Front Immunol. 2022;13:954936.
Sacher T, Andrassy J, Kalnins A, Dölken L, Jordan S, Podlech J, et al. Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog. 2011;7:e1002366.
Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, Hermans IF. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J Immunol. 2009;183:7732–42.
Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci Usa. 2009;106:1524–9.
Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol. 2005;169:569–76.
Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol. 2008;38:2369–76.
Nolte MA, Arens R, Kraus M, van Oers MH, Kraal G, van Lier RA, et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol. 2004;172:3620–7.
Tumanov A, Kuprash D, Lagarkova M, Grivennikov S, Abe K, Shakhov A, et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity. 2002;17:239–50.
Lewis KL, Caton ML, Bogunovic M, Greter M, Grajkowska LT, Ng D, et al. Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity. 2011;35:780–91.
De Trez C, Schneider K, Potter K, Droin N, Fulton J, Norris PS, et al. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol. 2008;180:238–48.
Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity. 2005;22:439–50.
Satpathy AT, Briseño CG, Lee JS, Ng D, Manieri NA, Kc W, et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol. 2013;14:937–48.
Meena NK, Pattanayak SP, Ben-Nun Y, Benhamron S, Kumar S, Merquiol E, et al. mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity. Immunology. 2018;155:505–18.
Shou Y, Koroleva E, Spencer CM, Shein SA, Korchagina AA, Yusoof KA, et al. Redefining the Role of Lymphotoxin Beta Receptor in the Maintenance of Lymphoid Organs and Immune Cell Homeostasis in Adulthood. Front Immunol. 2021;12:712632.
Segura E, Amigorena S. Cross-Presentation in Mouse and Human Dendritic Cells. Adv Immunol. 2015;127:1–31.
Dutta P, Hoyer FF, Grigoryeva LS, Sager HB, Leuschner F, Courties G, et al. Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J Exp Med. 2015;212:497–512.
Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018;19:1057.
Manjappa S, Bhamidipati PK, Stokerl-Goldstein KE, DiPersio JF, Uy GL, Westervelt P, et al. Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen. Biol Blood Marrow Transplant. 2014;20:46–52.
Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117:530–41.
Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S, et al. B-cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med. 2012;209:1001–10.
Shen P, Roch T, Lampropoulou V, O’Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507:366–70.
de Gruijter NM, Jebson B, Rosser EC. Cytokine production by human B cells: role in health and autoimmune disease. Clin Exp Immunol. 2022;210:253–62.
Lino AC, Dörner T, Bar-Or A, Fillatreau S. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases. Immunol Rev. 2016;269:130–44.
Shen P, Fillatreau S. Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol. 2015;15:441–51.
Maerz JK, Trostel C, Lange A, Parusel R, Michaelis L, Schäfer A, et al. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses. Front Immunol. 2019;10:3093.
Graalmann T, Borst K, Manchanda H, Vaas L, Bruhn M, Graalmann L, et al. B-cell depletion impairs vaccination-induced CD8(+) T-cell responses in a type I interferon-dependent manner. Ann Rheum Dis. 2021;80:1537–44.
Molnarfi N, Schulze-Topphoff U, Weber MS, Patarroyo JC, Prod’homme T, Varrin-Doyer M, et al. MHC class II-dependent B-cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med. 2013;210:2921–37.
Rodríguez-Pinto D. B cells as antigen presenting cells. Cell Immunol. 2005;238:67–75.
Welsh RA, Song N, Sadegh-Nasseri S. How does B-cell antigen presentation affect memory CD4 T-cell differentiation and longevity?. Front Immunol. 2021;12:677036.
Keller SA, von Allmen CE, Hinton HJ, Bauer M, Muntwiler S, Dietmeier K, et al. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles. J Immunol. 2009;182:6261–6.
Backer R, Schwandt T, Greuter M, Oosting M, Jüngerkes F, Tüting T, et al. Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Proc Natl Acad Sci USA. 2010;107:216–21.
Bernhard CA, Ried C, Kochanek S, Brocker T. CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. Proc Natl Acad Sci USA. 2015;112:5461–6.
Mauvais FX, Hamel Y, Silvin A, Mulder K, Hildner K, Akyol R, et al. Metallophilic marginal zone macrophages cross-prime CD8(+) T cell-mediated protective immunity against blood-borne tumors. Immunity. 2025;58:843–60.e20.
Junt T, Tumanov AV, Harris N, Heikenwalder M, Zeller N, Kuprash DV, et al. Expression of lymphotoxin beta governs immunity at two distinct levels. Eur J Immunol. 2006;36:2061–75.
Tumanov AV, Grivennikov SI, Shakhov AN, Rybtsov SA, Koroleva EP, Takeda J, et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev. 2003;195:106–16.
Camara A, Lavanant AC, Abe J, Desforges HL, Alexandre YO, Girardi E, et al. CD169(+) macrophages in lymph node and spleen critically depend on dual RANK and LTbetaR signaling. Proc Natl Acad Sci USA. 2022;119.
Vanderkerken M, Baptista AP, De Giovanni M, Fukuyama S, Browaeys R, Scott CL, et al. ILC3s control splenic cDC homeostasis via lymphotoxin signaling. J Exp Med. 2021;218.
Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315:107–11.
Shin C, Han JA, Choi B, Cho YK, Do Y, Ryu S. Intrinsic features of the CD8α(-) dendritic cell subset in inducing functional T follicular helper cells. Immunol Lett. 2016;172:21–8.
Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hägerbrand K, Marsal J, et al. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity. 2013;38:958–69.
Tussiwand R, Everts B, Grajales-Reyes GE, Kretzer NM, Iwata A, Bagaitkar J, et al. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity. 2015;42:916–28.
Briseño, Satpathy CG, Davidson AT, JTt, Ferris ST, Durai V, et al. Notch2-dependent DC2s mediate splenic germinal center responses. Proc Natl Acad Sci USA. 2018;115:10726–31.
Matsuo S, Nabekura T, Shibuya K, Shibuya A. CD96 enhances the anti-viral activity of natural killer cells by promoting Ly49H-mediated activation during mouse cytomegalovirus infection. Mol Immunol. 2025;179:65–70.
Mitrović M, Arapović J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, et al. The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. J Virol. 2012;86:2165–75.
Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, et al. Natural killer cells promote early CD8 T-cell responses against cytomegalovirus. PLoS Pathog. 2007;3:e123.
Sabatino JJ, Jr, Zamvil SS, Hauser SL B-Cell Therapies in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2019;9.
Ramos-Casals M, Sanz I, Bosch X, Stone JH, Khamashta MA. B-cell-depleting therapy in systemic lupus erythematosus. Am J Med. 2012;125:327–36.
Clerico M, De Mercanti S, Artusi CA, Durelli L, Naismith RT. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab. Mult Scler. 2017;23:874–6.
de Mercanti S, Durelli L, Iudicello M, Artusi C, Barbero P, Guerrasio A, et al. Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report (P2.091). Neurology. 2016;86:P2.091.
Bogie JF, Boelen E, Louagie E, Delputte P, Elewaut D, van Horssen J, et al. CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis. Mult Scler. 2018;24:290–300.
Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, et al. Clonal expansions of CD8(+) T cells dominate the T-cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med. 2000;192:393–404.
Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell. 1993;73:1155–64.
Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T-cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17–27.
Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 1985;57:65–73.
Shen FW, Saga Y, Litman G, Freeman G, Tung JS, Cantor H, et al. Cloning of Ly-5 cDNA. Proc Natl Acad Sci USA. 1985;82:7360–3.
Büttner JK, Becker S, Fink A, Brinkmann MM, Holtappels R, Reddehase MJ, et al. Direct antigen presentation is the canonical pathway of cytomegalovirus CD8 T-cell priming regulated by balanced immune evasion ensuring a strong antiviral response. Front Immunol. 2023;14:1272166.
Bayerl F, Bejarano DA, Bertacchi G, Doffin AC, Gobbini E, Hubert M, et al. Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods. Eur J Immunol. 2023;53:e2249923.
Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–87.e29.
Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.
Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell‒cell communication from single-cell transcriptomics. Nat Protoc. 2025;20:180–219.